The death of IPOs is just the start. The whole world’s going private
A world where ordinary investors hold private equity alongside their share portfolio? Wall Street giant Marc Rowan thinks ...
thedailyupside2h
Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List
The Food and Drug Administration declared an end to the scarcity of Eli Lilly's highly in-demand weight-loss and diabetes ...
Texas attorney general sues insulin makers and pharmacy middlemen over high costs
Texas Attorney General Ken Paxton's office said on Thursday it had sued insulin makers Eli Lilly, Novo Nordisk and Sanofi.
Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...
Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellers
The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...
Daily Reporter8h
Eli Lilly’s weight-loss drugs no longer in shortage, FDA says
Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...
wfft9h
Eli Lilly and Company announces additional $4.5 billion investment in Indiana LEAP District
LEBANON, Ind. (WFFT) — Eli Lilly and Company announced another $4.5 billion investment in Lebanon’s LEAP Research and ...
The Magazine9h
Lilly announces new $4.5-billion advanced research and manufacturing site
Eli Lilly and Co. (Indianapolis, Ind.) announced a $4.5-billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing ...
Bill Gates-backed TerraPower Isotopes produces rare, radioactive ingredient sought for cancer drugs
Bill Gates visiting TerraPower Isotopes, the subsidiary of the nuclear power company TerraPower that he helped found. Gates ...
FiercePharma10h
Eli Lilly's shortage of diabetes and obesity drugs is over, halting competition with knock-offs
Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...
Lilly's weight-loss, diabetes drugs no longer in shortage, pressuring Hims and Hers' stock
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage, signaling that the company has succeeded in expanding ...
Eli Lilly & Co (LLY) Gets a Buy from Truist Financial
In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Eli Lilly & Co (LLY – Research ...